Evelo Biosciences Target of Unusually High Options Trading (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) was the target of unusually large options trading activity on Wednesday. Traders bought 1,885 put options on the stock. This represents an increase of 1,101% compared to the typical volume of 157 put options.

Evelo Biosciences Stock Performance

Shares of EVLO opened at $0.00 on Friday. The firm has a market cap of $9,491.50, a PE ratio of 0.00 and a beta of 1.50. Evelo Biosciences has a 1-year low of $0.00 and a 1-year high of $0.08.

Evelo Biosciences Company Profile

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.